MAPT and Alzheimer disease: Future studies will evaluate how patterns of Aβ deposition correlate with cognitive decline longitudinally, in addition to characterizing how other aspects of Alzheimer's disease pathology (e.g. tau, synaptic markers) may influence these correlations.